Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
about
AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future.Secreted tumor antigens - immune biomarkers for diagnosis and therapy.Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
P2860
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoantibody Signature Enhance ...... for Detection of Lung Cancer.
@en
Autoantibody Signature Enhance ...... for Detection of Lung Cancer.
@nl
type
label
Autoantibody Signature Enhance ...... for Detection of Lung Cancer.
@en
Autoantibody Signature Enhance ...... for Detection of Lung Cancer.
@nl
prefLabel
Autoantibody Signature Enhance ...... for Detection of Lung Cancer.
@en
Autoantibody Signature Enhance ...... for Detection of Lung Cancer.
@nl
P2093
P2860
P1476
Autoantibody Signature Enhance ...... for Detection of Lung Cancer.
@en
P2093
Andrea Murray
Graham F Healey
Herb F Sewell
John F R Robertson
Laura J Peek
Lynn Fredericks
Pierre P Massion
P2860
P304
P356
10.1016/J.JTHO.2016.08.143
P577
2016-09-08T00:00:00Z